🔴 Protara Therapeutics is trading 5.7% down in after-hours trading with no definitive catalyst identified

Protara Therapeutics is trading at $2.30 (-5.74%) in after-hours trading; no definitive catalyst has been established.

• No fresh company-specific announcement explaining the drop was identified; Protara’s latest listed release, dated October 15, covered completion of THRIVE-3 trial enrollment.
• Broader risk-off sentiment may be contributing. Reuters reported technology-stock losses and rising oil-related market unease on October 22; major indexes were also lower.